MX159034A - Procedimiento mejorado para obtener derivados substituidos de la benzilftalazinona - Google Patents
Procedimiento mejorado para obtener derivados substituidos de la benzilftalazinonaInfo
- Publication number
- MX159034A MX159034A MX8743A MX874385A MX159034A MX 159034 A MX159034 A MX 159034A MX 8743 A MX8743 A MX 8743A MX 874385 A MX874385 A MX 874385A MX 159034 A MX159034 A MX 159034A
- Authority
- MX
- Mexico
- Prior art keywords
- benzilftalazinone
- substituted derivatives
- improved procedure
- obtaining substituted
- group
- Prior art date
Links
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 methoxyethyl group Chemical group 0.000 abstract 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3433776 | 1984-09-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX159034A true MX159034A (es) | 1989-04-13 |
Family
ID=6245402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX8743A MX159034A (es) | 1984-09-14 | 1985-09-10 | Procedimiento mejorado para obtener derivados substituidos de la benzilftalazinona |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4704387A (cg-RX-API-DMAC10.html) |
| EP (1) | EP0174464B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JPH0699425B2 (cg-RX-API-DMAC10.html) |
| AT (1) | ATE49205T1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA1263652A (cg-RX-API-DMAC10.html) |
| DD (1) | DD240205A5 (cg-RX-API-DMAC10.html) |
| DE (1) | DE3575135D1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK167118B1 (cg-RX-API-DMAC10.html) |
| ES (2) | ES8605509A1 (cg-RX-API-DMAC10.html) |
| GR (1) | GR852219B (cg-RX-API-DMAC10.html) |
| HU (1) | HU197740B (cg-RX-API-DMAC10.html) |
| IE (1) | IE64839B1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL75989A0 (cg-RX-API-DMAC10.html) |
| MX (1) | MX159034A (cg-RX-API-DMAC10.html) |
| PT (1) | PT81122B (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA856524B (cg-RX-API-DMAC10.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2031813T3 (es) * | 1985-11-11 | 1993-01-01 | Asta Pharma Ag | Procedimiento para la preparacion de derivados de 4-bencil-1-(2h)-ftalazinona. |
| EP0289939A1 (de) * | 1987-05-08 | 1988-11-09 | ASTA Pharma AG | Neue 4-Benzyl-1-(2H)-phthalazinon-Derivate mit einem Aminosäurerest |
| DE3877904D1 (de) * | 1987-11-13 | 1993-03-11 | Asta Pharma Ag | Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge. |
| US5232919A (en) * | 1987-11-13 | 1993-08-03 | Asta Pharma Aktiengesellschaft | Azelastine embonate and compositions which contain it |
| US5271946A (en) * | 1988-04-20 | 1993-12-21 | Asta Pharma Aktiengesellschaft | Controlled release azelastine-containing pharmaceutical compositions |
| MC2025A1 (fr) * | 1988-04-20 | 1990-04-25 | Asta Pharma Ag | Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee |
| EP0396069B1 (de) * | 1989-05-05 | 1994-06-22 | ASTA Medica Aktiengesellschaft | Salze des Azelastins mit verbesserter Löslichkeit |
| JPH04198180A (ja) * | 1990-11-28 | 1992-07-17 | Eezai Kagaku Kk | ベンジルフタラゾン誘導体の製造方法 |
| DE4207234A1 (de) * | 1992-03-07 | 1993-09-09 | Asta Medica Ag | Neue aminocarbonsaeure-derivate mit antiallergischer/antiasthmatischer wirkung und verfahren zu deren herstellung |
| US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
| ES2704482T3 (es) | 2004-11-24 | 2019-03-18 | Meda Pharmaceuticals Inc | Composiciones que comprenden azelastina y sus métodos de uso |
| US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
| US20090105225A1 (en) * | 2006-04-20 | 2009-04-23 | Glaxo Group Limited | 2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists |
| ATE525370T1 (de) * | 2007-10-11 | 2011-10-15 | Glaxo Group Ltd | Phthalazin- und pyridoä3,4- düpyridazinverbindungen als h1-rezeptor- antagonisten |
| EP3061501A1 (en) | 2015-02-27 | 2016-08-31 | Rottapharm Ltd. | Composition for the treatment of acne |
| EP3117825A1 (en) | 2015-07-16 | 2017-01-18 | Rottapharm S.p.A. | Oral formulation comprising berberine and morus alba extract |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1293565A (en) * | 1969-05-03 | 1972-10-18 | Aspro Nicholas Ltd | Aminophthalazines and pharmaceutical compositions thereof |
| CH572914A5 (cg-RX-API-DMAC10.html) * | 1971-01-22 | 1976-02-27 | Asta Werke Ag Chem Fab | |
| DE2114884A1 (de) * | 1971-03-27 | 1972-10-12 | Cassella Farbwerke Mainkur Ag, 6000 Frankfurt | Basisch substituierte Derivate des 1(2H)-Phthalazinons |
| US3813384A (en) * | 1972-01-17 | 1974-05-28 | Asta Werke Ag Chem Fab | Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof |
| US4665181A (en) * | 1984-05-17 | 1987-05-12 | Pennwalt Corporation | Anti-inflammatory phthalazinones |
-
1985
- 1985-07-12 AT AT85108760T patent/ATE49205T1/de not_active IP Right Cessation
- 1985-07-12 EP EP85108760A patent/EP0174464B1/de not_active Expired - Lifetime
- 1985-07-12 DE DE8585108760T patent/DE3575135D1/de not_active Expired - Lifetime
- 1985-08-01 IL IL75989A patent/IL75989A0/xx not_active IP Right Cessation
- 1985-08-12 US US06/764,995 patent/US4704387A/en not_active Expired - Fee Related
- 1985-08-27 ZA ZA856524A patent/ZA856524B/xx unknown
- 1985-09-10 MX MX8743A patent/MX159034A/es unknown
- 1985-09-11 JP JP60199655A patent/JPH0699425B2/ja not_active Expired - Lifetime
- 1985-09-12 GR GR852219A patent/GR852219B/el unknown
- 1985-09-12 DD DD85280568A patent/DD240205A5/de not_active IP Right Cessation
- 1985-09-13 DK DK416585A patent/DK167118B1/da not_active IP Right Cessation
- 1985-09-13 ES ES546959A patent/ES8605509A1/es not_active Expired
- 1985-09-13 CA CA000490641A patent/CA1263652A/en not_active Expired
- 1985-09-13 HU HU853462A patent/HU197740B/hu not_active IP Right Cessation
- 1985-09-13 IE IE227085A patent/IE64839B1/xx not_active IP Right Cessation
- 1985-09-13 PT PT81122A patent/PT81122B/pt not_active IP Right Cessation
- 1985-09-13 ES ES546971A patent/ES8605510A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES546959A0 (es) | 1986-03-16 |
| US4704387A (en) | 1987-11-03 |
| DD240205A5 (de) | 1986-10-22 |
| ES8605509A1 (es) | 1986-03-16 |
| EP0174464B1 (de) | 1990-01-03 |
| IE852270L (en) | 1986-03-14 |
| HUT38340A (en) | 1986-05-28 |
| HU197740B (en) | 1989-05-29 |
| ES8605510A1 (es) | 1986-03-16 |
| CA1263652A (en) | 1989-12-05 |
| IL75989A0 (en) | 1985-12-31 |
| IE64839B1 (en) | 1995-09-06 |
| JPS6172782A (ja) | 1986-04-14 |
| DK416585D0 (da) | 1985-09-13 |
| GR852219B (cg-RX-API-DMAC10.html) | 1986-01-14 |
| DK167118B1 (da) | 1993-08-30 |
| DK416585A (da) | 1986-03-15 |
| ZA856524B (en) | 1986-04-30 |
| EP0174464A2 (de) | 1986-03-19 |
| PT81122A (de) | 1985-10-01 |
| EP0174464A3 (en) | 1986-12-30 |
| JPH0699425B2 (ja) | 1994-12-07 |
| ATE49205T1 (de) | 1990-01-15 |
| DE3575135D1 (de) | 1990-02-08 |
| PT81122B (pt) | 1988-01-22 |
| ES546971A0 (es) | 1986-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX159034A (es) | Procedimiento mejorado para obtener derivados substituidos de la benzilftalazinona | |
| ES545771A0 (es) | Un procedimiento para preparar derivados de quiniona. | |
| ES544644A0 (es) | Un procedimiento para la preparacion de derivados de carboxamidoadenosina. | |
| ES557316A0 (es) | Procedimiento para la obtencion de derivados de 5-amino-4-hidrovalerilo. | |
| ES546236A0 (es) | Un procedimiento para la preparacion de derivados de bencimidasol. | |
| ES546189A0 (es) | Procedimiento de obtencion de derivados de 4-aril-1,4-dihi- dropiridinas | |
| ES552943A0 (es) | Un procedimiento para la preparacion de derivados de tia(oxa) diazol | |
| ES525256A0 (es) | Procedimiento para la obtencion de 2-nitro-1,1-etendiaminas | |
| ES514340A0 (es) | "procedimiento de obtencion de nuevos derivados de piperazina". | |
| SE8601646D0 (sv) | Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof | |
| ES544753A0 (es) | Un procedimiento para la preparacion de carbapenems. | |
| ES545009A0 (es) | Procedimiento de preparacion de nuevas fenil-naftiridinas. | |
| ES539942A0 (es) | Un procedimiento para la preparacion de derivados de hidantoina. | |
| ES486422A0 (es) | Un procedimiento para la preparacion de nuevos compuestos iminicos heterociclicos. | |
| ES493462A0 (es) | Un procedimiento de preparacion de dihidro-2,3-dime- til-2,2-hidroxi-7-benzofurano | |
| ES555459A0 (es) | Procedimiento para preparar derivados de saframicina a. | |
| ES8303412A1 (es) | Procedimiento de obtencion de nuevas xantinas con actividad farmacologica | |
| ES491999A0 (es) | Un procedimiento mejorado para la preparacion de compuestos de trialcoxisilanol estericamente impedidos. | |
| ES529736A0 (es) | Un procedimiento para la preparacion de 3-formil-2-nitrometilen-tetrahidro-2h-1, 3-tiazina | |
| ES2072288T3 (es) | Preparacion de enantiomeros de dropropizina. | |
| MX5840A (es) | Procedimiento para la preparacion de compuestos heterociclicos. | |
| ES548244A0 (es) | Un procedimiento para la preparacion de derivados de 5-cetomilbemicina. | |
| ES547438A0 (es) | Un procedimiento para la preparacion de derivados de carbaprem. | |
| ES548044A0 (es) | Un procedimiento para la preparacion de un derivado de fluorescencia. | |
| AR240826A1 (es) | Procedimiento para preparar derivados de 7beta-(2-(2-aminotiazol-4-il)2-alcoxiiminoacetamido)-3-(1-piridinometil)-3-cefem-4-carboxilato |